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Abstract
An explanatory framework, referred to as the attitude/social influence/self-efficacy-model (ASE-model), was utilised to explain future
self-reported adherence of adolescents to daily inhaled prophylactic asthma medication. The objective was to investigate the long-term
influence of these earlier reported cognitive variables and other psychological and medical determinants on self-reported adherence 1 year
later. Data were collected, via a questionnaire, from 86 adolescents with asthma (aged 11 through 18 years) recruited from outpatient
clinics. Adherence was assessed by asking the patients to give themselves a report mark for adherence. The results of the multiple
regression analyses showed that the three major ASE-variables were predictors of self-reported adherence to a moderate degree
(R2 ¼ 0:21). Previous self-reported adherence was found to be the best predictor of self-reported adherence to prophylactic asthma
medication 1 year later (R2 ¼ 0:45). The results of this study could be useful in the development of interventions to enhance adherence to
asthma medication. In future, such interventions should focus on feelings of shame about having asthma and promoting healthy habits, such
as adherence to medication. # 2002 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
Asthma is a chronic inflammatory disorder of the airways,
which causes recurrent episodes of wheezing, breathless-
ness, tightness of the chest, and coughing, particularly at
night and/or in the morning. These symptoms are usually
associated with widespread, but variable airway limitation
that is at least partly reversible, either spontaneously or with
treatment [1]. Patients with more than a mild form of asthma
require treatment involving daily inhalation of prophylactic
asthma medication (corticosteroids, cromones) to prevent
and reverse this airway inflammation [1]. In addition,
bronchodilatory drugs are indicated when patients suffer
from asthma symptoms.
Patients with asthma can adopt a range of behaviour
patterns themselves in order to manage their disease. Adher-
ence to the prescribed medication is an important aspect of
the self-management of asthma; nevertheless, non-adher-
ence to prophylactic medication is common, and may have
serious consequences. In a study investigating the causes of
death among adolescents with asthma, the authors con-
cluded that poor adherence played a substantial role [2].
Self-reporting is the most commonly used method in the
assessment of adherence to asthma medication [3,4]. Dekker
et al. [5] found a mean of 8 for self-reported adherence on a
scale of 0 to 10 in adolescents and adults with asthma.
Adherence can also be defined as the percentage of pre-
scribed doses actually taken. Reported degrees of adherence
to inhaled prophylactic medication in children and adoles-
cents with asthma vary between 30% [6] and 58% [7].
Various determinants of adherence have been described:
the quality of the doctor–patient relationship [8–10], the
complexity of the treatment regimen [9–11], feelings of
shame about having asthma [12], severity of the asthma,
demographical factors, such as sex and ethnic origin [10,13],
and age, for which adolescence in particular is a negative
factor [14].
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A potentially informative model which can be used to
describe the determinants of adherence among adolescents
with asthma is the Attitudes, Social influences and self-
Efficacy (ASE-model) [15,16] (Fig. 1). This model has been
successfully applied in several studies to explain various
aspects of health behaviour, such as fruit and vegetable
consumption [17,18], fat intake [19], the use of sunbeds
[20], participation in employee fitness programs [21], smok-
ing [16,22,23] and adherence to hormone replacement ther-
apy [24]. The ASE-model originated from the theory of
reasoned action (TRA) [25,26]. A new dimension, namely
Bandura’s concept of self-efficacy, has been added to the
TRA concepts to form the ASE-model [15]. In the ASE-
model, it is assumed that intention and subsequent behaviour
are primarily determined by the following cognitive vari-
ables: attitudes, social influences, and self-efficacy expecta-
tions. Moreover, the model postulates that intention predicts
subsequent behaviour. A person’s attitude towards a specific
behaviour (e.g. inhaling asthma medication) is a result of the
consequences that a person expects from performing the
behaviour (e.g. ‘‘inhaling medication will make me fat’’).
Social influences can be described as the processes whereby
people directly or indirectly influence the thoughts, feelings,
and action of others. Self-efficacy expectations pertain to a
person’s belief in his or her ability to perform the desired
behaviour [17].
Cross-sectional analyses [27] indicated that the three major
ASE-variables were moderately strong predictors of self-
reported adherence to prophylactic asthma medication in
adolescents. In particular, negative self-efficacy expectations
and the intention to adhere appeared to be related to self-
reported adherence. External factors did not contribute sig-
nificantly to the prediction of adherence. However, only
longitudinal research offers the opportunity to investigate
the long-term influence of cognitive variables on adherence.
The present study investigates the degree to which the
following cognitive variables: attitudes, social influences,
self-efficacy expectations and intention can be used to
predict self-reported adherence to prophylactic asthma med-
ication 1 year later in adolescents. In response to the
suggestion that previous behaviour will have no substantial
unique contribution in predicting behaviour after controlling
for attitude, social influences, self-efficacy, and intention
[28], self-reported adherence at baseline was also included
to test this theory.
2. Methods
2.1. Respondents and procedure
Patients were recruited from six paediatric outpatient
clinics. Two of these outpatient clinics were in academic
teaching hospitals, one was in a specialised asthma centre,
and the other three were in district hospitals. The criteria for
inclusion were: asthma diagnosed by a physician; treatment
prescribed by a paediatrician with daily inhalation of pro-
phylactic asthma medication during a preceding period of at
least 2 months; aged from 11 through 18 years; attending
secondary school; ability to fill in a questionnaire in the
Dutch language. Patients who met the inclusion criteria were
informed about the study by their paediatrician, and both the
patient and the parent(s) received written information
regarding the study. Patients had at least 24 h to decide
on whether or not they were willing to participate. The study
protocol was approved by the Ethical Review Board of each
participating centre, and all participants and their parents
gave informed consent. Participants took part in a rando-
mised controlled intervention study aimed at enhancing
adherence in adolescents with asthma. They were randomly
allocated to either the intervention program or to usual care
by their paediatrician.
2.2. Measurements
Data were collected at baseline (T0) and after 12 months
follow-up (T1). The participants filled in questionnaires
which were based on the concepts of the ASE-model and
other psychological, medical and demographical determi-
nants. The paediatricians filled in a form on which they were
asked to provide medical data. Details regarding these
variables will be described in the following sections.
Cronbach’s a coefficients of internal consistency were
calculated for variables constructed by the summation of
items scores at baseline; only those with coefficients >0.60
were selected for further analysis.
Fig. 1. ASE-model.
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2.3. Dependent variable
Adherence was assessed at baseline and after 12 months
follow-up by means of self-reports. Participants were asked
to score their adherence on a 10-point scale (range:
1 ¼ never take prophylactic medication to 10 ¼ always take
prophylactic medication, as prescribed).
2.4. Psychological determinants (ASE)
The ASE-variables were operationalised in several ques-
tions, and for each variable a sum-score was calculated. The
questions were based on the results of a number of quali-
tative pilot studies concerning the attitudes, social influences
and self-efficacy expectations of adolescents with asthma
[29]. The concept of attitude was sub-divided into two
scales: a positive and a negative attitude to taking medica-
tion. The concept of self-efficacy expectations was also
sub-divided into two scales: self-efficacy directed at dis-
playing the desired behaviour, and self-efficacy aimed at
overdosing.
Positive attitude (pro) was based on three questions about
one statement, involving three different 7-point scales (A:
1 ¼ ‘very good’ to 7 ¼ ‘very bad’; B: 1 ¼ ‘very wise’ to
7 ¼ ‘very foolish’; C: 1 ¼ ‘very harmless’ to 7 ¼ ‘very
damaging’). Participants were asked whether they agreed
with the following statement: ‘‘If I took my asthma medicine
every day that would be: . . .’’. Sum-scores were obtained
after reverse scoring of the scales. Therefore, high scores
indicate a positive attitude towards taking prophylactic
asthma medication daily (Cronbach’s a ¼ 0:70).
Negative attitude (con) was based on six statements on a
4-point scale (1 ¼ ‘strongly agree’ to 4 ¼ ‘strongly dis-
agree’). Participants were asked whether they agreed with
statements regarding their asthma medication, such as ‘‘I
don’t always take my medicine because I don’t want people
to pity me’’. High scores indicate a less negative attitude
towards taking medication (Cronbach’s a ¼ 0:67).
Social influences was based on six statements on a 5-point
scale (1 ¼ ‘totally disagree’ to 5 ¼ ‘totally agree’). Partici-
pants were asked whether they agreed with statements
regarding the opinion of four groups of important people
in their environment with regard to taking asthma medica-
tion daily. An example of such a statement is: ‘‘My parents/
carers think I should take my asthma medicine every day’’.
High scores indicate a high degree of perceived social
influence (Cronbach’s a ¼ 0:87).
Self-efficacy directed towards the desired behaviour was
based on four statements on a 4-point scale (1 ¼ ‘strongly
disagree’ to 4 ¼ ‘strongly agree’). Participants could indi-
cate the probability of their ability to perform the desired
behaviour with respect to asthma medication. This was
intended to determine how participants evaluated their
self-efficacy with regard to the desired behaviour. An exam-
ple of such a statement is: ‘‘I always take my medication
very carefully’’. High scores indicate positive expectations
of a participant to realise the desired behaviour with respect
to asthma medication (Cronbach’s a ¼ 0:67).
Self-efficacy aimed at overdosing was based on two
statements on a 4-point scale (1 ¼ ‘strongly agree’ to
4 ¼ ‘strongly disagree’) to determine what patients think
about taking more medication than prescribed by a physi-
cian. Participants could indicate the probability of their
ability to refrain from taking more medication than pre-
scribed by the physician. An example of such a statement is:
‘‘If I’m very short of breath, I take more medicine than my
doctor told me to take’’. High scores indicate that the patient
is not inclined to take more medication than prescribed by
the physician (Cronbach’s a ¼ 0:71).
Intention was assessed on the basis of one statement on a
7-point scale (1 ¼ ‘extremely unlikely’ to 7 ¼ ‘extremely
likely’). The statement: ‘‘I intend to take my asthma
medicine every day’’ had to be scored by indicating the
probability of this intention.
2.5. External factors
Apart from demographic data (sex, age and ethnic origin),
the following external factors (psychological and medical
determinants) were assessed.
Feeling ashamed about having asthma was based on a
sub-scale of the ‘Respiratory Illness Opinion Survey’
(RIOS) [30,31], and consisted of seven questions on a 5-
point scale (1 ¼ ‘never’ to 5 ¼ ‘always’) on the subject of
feeling ashamed about having asthma. High sum-scores
indicate that the participant is ashamed of having asthma
(Cronbach’s a ¼ 0:62).
To determine the quality of communication with the
physician as perceived by the patient, a questionnaire
was developed, partly based on the questionnaire developed
by Richards et al. [32]. It also contained a question con-
cerning the perceived quality of treatment provided by
the physician and a question concerning the perceived
empathic attitude of the physician. In total, the question-
naire consisted of 11 questions. A high score indicates
that the participant had a positive perception of the qua-
lity of communication with the physician (Cronbach’s
a ¼ 0:80).
The extent to which asthma symptoms were severe enough
to cause inconvenience to the patient during the previous 7
days [33] was assessed by asking the participant one ques-
tion on a 5-point scale (1 ¼ ‘not at all bothered, no symp-
toms’ to 5 ¼ ‘severely bothered, unable to function’) about
the inconvenience experienced during the previous 7 days. A
high score indicates that the participant was severely both-
ered by asthma symptoms.
The severity of asthma, according to the physician [34]
was based on the prescribed amount and type of medication,
in the following categories: mild to moderate (stable with
cromones); moderate to severe (stable with 400 mg inhaled
corticosteroids per day); severe (>400 mg inhaled corticos-
teroids per day).
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For the frequency of prescribed dosage of daily prophy-
lactic asthma medication, the physician was asked to indi-
cate how many times during the day the patient was
instructed to take prophylactic medication according to
the prescription.
2.6. Statistical analyses
A comparison was made of the baseline self-reported
adherence, intention, demographic, and medical variables of
participants whose self-reported adherence was available at
T1, and of participants who did not answer the question
concerning self-reported adherence, withdrew from the
study or no longer had to use prophylactic asthma medica-
tion at T1 (defined as ‘drop-outs’). For the first four vari-
ables, t-tests were performed. For variables which were
scored on a nominal or ordinal scale, percentages are pre-
sented. For these variables w2-tests and a Wilcoxon-test,
respectively, were performed.
Linear regression analysis was applied to examine the
relationship between self-reported adherence at 12 months
follow-up (T1) and its putative determinants at baseline
(T0). The regression models were also fitted for intention at
T1 as the dependent variable. To determine whether the
ASE-variables explain any variation in self-reported adher-
ence and intention, all ASE-variables were included in the
linear regression models. External factors were only con-
sidered for inclusion in the model if they had a Pearson’s
correlation coefficient of at least 0.15 with self-reported
adherence. Determinants were identified by means of back-
ward elimination, with P ¼ 0:10 as criterion, in order to
retain potentially related variables. Initially, each indivi-
dual component of the ASE-model (external factors, ASE-
variables, and intention) was entered, independent of the
other components, at first univariately, later multivariately,
until the full ASE-model had been entered into the regres-
sion model. In order to adjust for the negligible effect of the
intervention program, an indicator variable was forced into
the regression model, and therefore, controlled for in the
analyses.
3. Results
3.1. Description of the study population
Of the 165 eligible patients identified, 53 adolescents
were unwilling to participate in the study, but were willing to
make self-reports of their adherence. The mean self-reported
adherence in this group was 7.5 (S.D. 1.6) which showed no
statistically significant difference from that of the partici-
pants at baseline. The remaining 112 adolescents were
willing to participate in the study. Between T0 and T1, 15
participants withdrew from the study. Reasons for with-
drawal were: lack of time (n ¼ 1), moved (n ¼ 1), family
circumstances (n ¼ 2), moving to another hospital (n ¼ 1),
lack of motivation or no reason given (n ¼ 10). Thus, 97
participants were available for further analysis at T1. At 12
months follow-up (T1) four participants no longer had to use
prophylactic asthma medication, and were therefore,
excluded from the analyses. Consequently, data of 86 parti-
cipants concerning self-reported adherence were used for the
analysis. Differences between participants who were still
available at T1 and drop-outs are presented in Table 1. There
was one statistically significant difference between the
groups. Drop-outs were more often of the male sex.
3.2. Determinants of adherence
At baseline the mean score for self-reported adherence
was 7.5 (S.D. 1.7), and at 12 months follow-up it was 7.6
(S.D. 1.7).
Of the external factors, only the variable feeling ashamed
about having asthma was correlated with self-reported
adherence at T1 (r ¼ 0:16). This external factor was
selected for further analyses. Although the randomised
controlled trial was negative, in the sense that no differences
between the intervention and usual care could be found, the
type of intervention was always controlled for, in all regres-
sion models. The indicator variable for type of intervention
was entered in a univariate regression model, and explained
only 3% of the variance in self-reported adherence (Table 2)
and 2% of the variance in intention (data not shown). In
the univariate regression models, statistically significant
associations were found between self-efficacy directed
at the desired behaviour, intention and self-reported adher-
ence at T0, on the one hand, and self-reported adherence at
T1 as dependent variable on the other hand. The explained
Table 1






Self-reported adherence 7.5 (1.7) 6.8 (2.1) 0.12
Intention 6.0 (1.0) 5.5 (1.4) 0.09
Age 13.7 (1.3) 13.8 (1.3) 0.72
Duration of asthma 10.2 (3.5) 11.0 (3.8) 0.36





Mild to moderate 5 1 0.94
Moderate to severe 54 15
Severe 27 8
a Baseline characteristics of participants and drop-outs on self-reported
adherence, intention, demographic and medical variables. ‘Drop-outs’
were defined as participants who did not report their adherence at T1,
withdrew from the study or did no longer had to use prophylactic asthma
medication at T1. Mean values and S.D. are presented of the first four
variables, for which t-tests were performed. For the other variables
percentages are presented, as these variables were scored on a nominal or
ordinal scale. For these variables w2-tests and a Wilcoxon-test, respectively,
were performed.
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variance in self-reported adherence at T1 varied for these
determinants between 1 and 44% (Table 2).
The most important determinants of self-reported adher-
ence at 12 months follow-up (T1), adjusted for type of
intervention, were feeling ashamed about having asthma, a
positive attitude to taking medication and intention. The
external factor feeling ashamed about having asthma
explained 17% of the variance in self-reported adherence
(model 1), the ASE-variables 21% (model 2), and intention
11% (model 3). The percentage of explained variance of
the full model was 23% of the variance in self-reported
adherence (model 4). When self-reported previous beha-
viour was entered into the regression model, it appeared
to be the strongest predictor of future behaviour. This
variable explained 45% of the variance in self-reported
adherence (model 5). After entering self-reported previous
behaviour into the full model (model 6), statistically sig-
nificant associations were found between feeling ashamed
about having asthma, social influences (sub-scale: tea-
chers), intention, self-reported adherence at T0 and self-
reported adherence at T1. In this model, the explained
variance in self-reported adherence was 53% (model 6;
Table 3).
The ASE-model postulates that intention predicts beha-
viour. Therefore, the most important determinants of inten-
tion were also identified by means of multiple regression
analysis. Statistically significant associations were found
between feeling ashamed about having asthma, a positive
attitude to taking medication, self-efficacy directed toward
the desired behaviour, and intention at T0, on the one hand,
and intention at T1 as dependent variable on the other hand.
The explained variance in intention varied between 4 and
24% (data not shown).
Table 2
Results of univariate linear regression analyses with self-reported
adherence at 12 months follow-up as dependent variablea
Self-reported adherence (n ¼ 86)
B (P) R2
Type of intervention 0.57 (0.11) 0.03
Intention 0.50 (0.00) 0.10
Self-reported adherence at T0 0.65 (0.00) 0.44
Attitude
Pro 0.08 (0.39) 0.01
Con 0.12 (0.09) 0.04
Social influences
Parents 0.37 (0.33) 0.01
Peers 0.02 (0.71) 0.00
Teachers 0.25 (0.14) 0.03
Physician 0.79 (0.15) 0.03
Self-efficacy
Directed at desired behaviour 0.22 (0.01) 0.09
Aimed at overdosing 0.10 (0.39) 0.01
External factor
Feeling ashamed
About having asthma 0.16 (0.00) 0.11
a B: regression coefficient; range of self-reported adherence [1–10].
Table 3
Results of multiple linear regression analyses with self-reported adherence at 12 months follow-up as dependent variablea
Self-reported adherence (n ¼ 86)
Model 1 Model 2 Model 3 Model 4 Model 5 Model 6
B (P) B (P) B (P) B (P) B (P) B (P)
Correction for type of intervention 0.77 (0.03) 0.31 (0.36) 0.35 (0.33) 0.55 (0.10) 0.35 (0.20) 0.49 (0.07)
Intention 0.46 (0.01) 0.52 (0.00)








Physician 0.65 (0.03) 0.74 (0.06)
Self-efficacy
Directed at desired behaviour 0.29 (0.00)
Aimed at overdosing
External factor
Feeling ashamed 0.18 (0.00) 0.17 (0.00) 0.15 (0.00)
About having asthma
R2 0.17 0.21 0.11 0.23 0.45 0.53
a B: regression coefficient; range of self-reported adherence [1–10]. The different regression models 1 up to and including 6 are presented in an increasing
sequence from left to right. These final regression models were obtained by employing a backward variable reduction technique (P ¼ 0:10), participation in
the intervention program was always controlled for in all regression models.
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4. Discussion
The ASE-model was used in the present study to explain
self-reported adherence to asthma medication 1 year later,
by investigating the long-term influence of cognitive vari-
ables reported at T0. The results of the multiple regression
analyses showed that the three major ASE-variables were
predictors of self-reported adherence to a moderate degree.
Previous self-reported adherence was found to be the best
predictor of self-reported adherence to prophylactic asthma
medication 1 year later.
Ajzen’s suggestion [28] that previous behaviour makes no
significant unique contribution to predicting behaviour after
controlling for attitude, social influences, self-efficacy and
intention, is not supported by the findings of this study. The
results are more in accordance with the findings of Lechner
et al. [35] and de Vries et al. [16]. In the study carried out by
Lechner et al. [35], it was found that previous behaviour with
regard to breast cancer screening was one of the most
important determinants of behavioural intentions and of
participation in the second breast screening cycle. De Vries
et al. [16] found that previous behaviour was the strongest
predictor of future smoking behaviour. Triandlis [36] stated
that as behaviour takes place repeatedly, habit increases and
becomes a better predictor of behaviour than behavioural
intentions. To some extent, this frequently repeated beha-
viour occurs habitually, without the mediation of attitudes,
social influences, self-efficacy and intention. This also
implies that a person might be less aware of the influence
of cognitive variables on the occurrence of this behaviour,
and therefore, behaves in an accustomed way without
making a conscious decision to act. As a result, this beha-
viour may be less clearly predicted by cognitive variables
[36]. To account for this effect, habit should be included in
the analyses. This is usually done by operationalising habit
as previous behaviour. Self-reported adherence to prophy-
lactic asthma medication 1 year later appeared to be most
clearly predicted by self-reported previous behaviour. This
may indicate that adherence to prophylactic asthma medica-
tion can be considered as a habit, and should be treated as a
habit if the intention is to enhance adherence. Healthy habits
are quite difficult to establish, and once unhealthy habits
have been formed, they are hard to break [37]. Therefore,
healthy habits should be established as soon as possible if
unhealthy habits are to be prevented.
The present study has some possible limitations. It was
not primarily designed as a cohort study, but as a randomised
controlled trial. The intervention, however, appeared to have
had no effect on adherence to prophylactic asthma medica-
tion, and participation in the intervention program was
controlled for in the analyses. It was not possible to compare
the adolescents who participated in the study with those who
refused to participate, and it is conceivable that there may be
differences on other relevant characteristics. A major limita-
tion of this study pertains to the relatively high percentage of
drop-outs and the difference between the participants and
the drop-outs. Comparing baseline self-reported adherence,
intention, demographic and medical characteristics of par-
ticipants and drop-outs showed one statistically significant
difference between these two groups. Drop-outs were more
often of the male sex. One other shortcoming of this study
might involve the limited operationalisation of the ASE-
concepts. Finally, another possible limitation concerns the
use of self-report as method to assess adherence. As has been
stated by Berry et al. [38], this method of assessing adher-
ence is probably not related in any one-to-one way to actual
adherence behaviour. Ley [3], however, after reviewing the
different methods for assessing adherence, stated that the
most popular method, i.e. patient reports, correlates signifi-
cantly with other methods of measurement. The opinion of
DiMatteo and DiNicola [39] is that one should seek to
understand the reporting of adherence by patients, just as
one seeks to understand adherence behaviour itself. It should,
therefore, be emphasised that the lack of existence of a
feasible method for the assessment of adherence is still one
of the drawbacks faced in any study concerning adherence to
inhaled asthma medication. It is important that future studies
on adherence make use of reliable and valid electronic
devices. However, these methods are also open to criticism.
5. Conclusion
The general conclusion is that the ASE-model provides
some insight into the factors influencing adherence to
asthma medication. Haynes et al. [40] stated that to achieve
the full benefits of current medical therapies, we need a
better understanding of adherence. Unfortunately, most
strategies to enhance adherence with long-term medication
prescription, studied before 1997, have not been very effec-
tive. Trials concerning adherence interventions provide little
evidence that adherence can be improved consistently [40].
5.1. Impractice implication
Haynes et al. [40] stated that effective ways to help people
adhere to medical treatment would have far greater effects
on health than any treatment itself. The results of the present
study could be useful in the development of interventions of
this kind. Future interventions to enhance adherence to
asthma medication should certainly focus on feelings of
shame about having asthma and establishing healthy habits,
such as adherence [37]. In general, healthy habits should be
established as soon as possible, to prevent unhealthy habits
being formed.
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